Guru Ownership Trend
Guru Analysis for Prime Medicine, Inc. (PRME)
Prime Medicine, Inc. (PRME), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $24.73 M.
Top institutional holders include Catherine Wood and Renaissance Technologies.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $329,080.9 net outflow during the quarter.
Recent activity highlights Paul Tudor Jones who opened a new position. Conversely, Cliff Asness reduced exposure by 2.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Prime Medicine, Inc. (PRME)
Major holders include Catherine Wood ($18.63 M), Renaissance Technologies ($3.99 M), Louis Moore Bacon ($2.77 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 7.49 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $329,080.9, with 1 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited PRME. The total reported sell value was $379,357.73.
Yes, 0 managers opened new positions in PRME, and 1 increased their existing holdings. The total reported buy value was $50,276.83.